It’s not difficult to find someone who has been impacted by cancer. According to the National Cancer Institute in 2016, an estimated 1,685,210 new cases of cancer will be diagnosed in the United States and 595,690 people will die from the disease. In addition, the number of people living beyond a cancer diagnosis reached nearly 14.5 million in 2014 and is expected to rise to almost 19 million by 2024. Newly approved cancer drugs cost an average of $10,000 per month, with some therapies topping $30,000 per month. This doesn’t include the cost of chemotherapy, provider fees, or lost income. These staggering statistics provide a bleak outlook for cancer patients. What if there was a better way to help patients? Could CBD provide any benefits? Let’s look deeper.
The endocannabinoid system (ECS) is a group of cannabinoid receptors located in the brain and throughout the central and peripheral nervous systems, consisting of neuromodulatory lipids and their receptors. There are two main types of receptors in the ECS, CB1 and CB2. CB1 receptors are primarily located in the central nervous system and brains of mammals, and CB2 are generally found in the peripheral nervous system. There are two main cannabinoids mammals produce- 2AG and Anandamide. Read more by clicking here
Our commitment to product quality and purity has driven HempMeds® to develop the strictest testing process in our industry, the Triple Lab Tested™ standard. We use ISO/IEC 17025:2005 accredited testing labs to examine our hemp oil and assure both its safety and consistency. These labs test our hemp oil for the concentration of cannabinoids, including CBD, CBDa, CBG, THC, and over a half dozen others. By testing our hemp oil three times during our production process, we ensure that our products are completely safe for use by you and your entire family.